Surgeon views regarding the adoption of a novel surgical innovation into clinical practice: systematic review

Nagarjun N Konda1,2, Thomas L Lewis3, Hugh N Furness4

  • 1Warwick Clinical Trials Unit, Warwick Medical School, The University of Warwick, Coventry, UK.

BJS Open
|January 24, 2024
PubMed
Abstract

Insights

Surgeons adopt new surgical innovations based on factors like clinical outcomes and cost. Barriers include lack of support and senior surgeon opinions, highlighting the need for evidence-based decision-making in surgical technology adoption.

Area of Science:

  • Surgical innovation adoption
  • Health technology assessment
  • Medical practice management

Background:

  • Haphazard adoption of new surgical technologies can lead to patient harm.
  • Misconceptions influence decisions regarding the adoption of novel surgical innovations.
  • Understanding surgeon decision-making is crucial for safe and effective technology integration.

Purpose of the Study:

  • To synthesize factors influencing a surgeon's decision to adopt a novel surgical innovation into clinical practice.
  • To identify facilitators and barriers to the adoption of new surgical technologies.

Main Methods:

  • Systematic literature search across multiple databases (MEDLINE, Embase, etc.) up to October 2022.
  • Included studies with surgeon views on novel surgical innovation adoption across various specialties.
  • Assessed study quality using the Critical Appraisal Skills Programme (CASP) tool for qualitative research.

Main Results:

  • 26 studies with 1112 participants (694 surgeons) from nine countries were analyzed.
  • Thematic synthesis identified five causal factors: structural, organizational, patient-level, provider-level, and innovation-based.
  • Key facilitators: improved clinical outcomes, cost-effectiveness, stakeholder support. Key barriers: lack of organizational support, senior surgeon views.

Conclusions:

  • Multiple complex, interacting factors influence the adoption of novel surgical innovations.
  • Further investigation is needed on surgeon and stakeholder views regarding evidence strength for widespread adoption.
  • A structured approach to evaluating surgical innovations is essential to mitigate risks and optimize patient care.